Biggest News Aggregation in the World
📰 Lee Gan News

Lee Gan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Lee Gan. Real-time updates on events, politics, business and more.

Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been [...] | Comunicati stampa CataniaOggi

29 gennaio 2021 15:38 Fonte: Adnkronos #salute-e-benessere BEIJING and BRIDGEWATER, N.J., Jan. 29, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that Gan & Lee is dev...
Hollie Brissenden Julius Huang Prnewswire Gan Lee Pharmaceuticals Co Ltd Drug Administration Global Clinical Sciences Fast Track Designation

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science